pCR was defined as the absence of residual invasive cancer cells in the breast and axillary lymph nodes (ypT0/is +ypN0).10 Residual cancer burden (RCB) index was calculated using the web-based calculator (available on internet),25 by considering dimensions of the primary tumour, tumour bed ...
The PREDICT breast cancer is a well-known online calculator to estimate survival probability. We developed a new prognostic model, myBeST, due to the PREDICT tool's limitations when applied to our patients. This study aims to compare the performance of the two models for...
The widely used Western BRCA mutation prediction models underestimated the risk of having a BRCA mutation in Korean breast cancer patients. This study aimed to identify predictive factors for BRCA1/2 mutations and to develop a Korean BRCA risk calculator. The model was constructed by logistic regres...
Characterization of breast cancer tumors is critical in determining appropriate treatment options and predicting patient prognosis. The hormone receptor status and HER2 expression act as markers to direct drug treatments or to predict behavior of the disease. In addition to immunohistochemical properties, ...
Our aim was to develop an online Kaplan-Meier plotter which can be used to assess the effect of the genes on breast cancer prognosis.
Dr O’Regan on Sequencing Considerations in Advanced HR+ Breast Cancer Dr Weiss on the Role of Breast Imaging in Breast Cancer Treatment Decision-Making Dr Feldman on the Significance of the HER2-Low Classification in HER2+ Breast Cancer
Table 1 Characteristics of the 1800 triple-negative breast cancer patients. Full size table . Cutoff value for Ki-67 verified in the PSM cohort To define the most relevant cutoff value for Ki-67 distinguishing prognosis, we used the online tool “Cutoff Finder”. This method has been employed...
Triple-negative breast cancer, the poorest-prognosis breast cancer subtype, lacks clinically approved biomarkers for patient risk stratification and treatment management. Prior literature has shown that interrogation of the tumor-immune microenvironment
I asked about prognosis, but David said he doesn’t like to get into the “numbers game.” Everyone is different. At Princess Margaret, he explained, they practice evidence-based medicine and give “maximum treatment and expect the best outcomes.” He left and two nurses came in to obtain...
Anderson Cancer Center 10. The identification of reliable treat- ment endpoints is of crucial importance. It seems logical that a good response to chemotherapy in LABC would predict for better long-term prognosis and ulti- mately for survival. The achievement of a pCR has...